Moreover, high RAB5 expression is associated with low E-cadherin expression in clinical pancreatic cancer samples, and RAB5 suppression activates the morphology and ability of proliferation, invasion, and migration of pancreatic cancer cell lines. Here, RAB5A is linked to familial pancreatic carcinoma.